To be eligible for this study, patients must meet several criteria, including but not limited to the following:
- Patients must have metastatic uveal melanoma.
- Patients must have recovered from the side effects of prior treatment.
- Patients must be age 18 or older.
For more information about this study and to inquire about eligibility, please contact Dr. Paul Chapman at 646-888-4162.